Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Oncol Rep. 2003 Jan-Feb;10(1):197-206.
Oncol Rep. 2003.
PMID: 12469169
Clinical Trial.
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
Mantovani G, Proto E, Massa E, Mulas C, Madeddu C, Mura L, Mudu MC, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Tore G, Mura M, Amichetti M, Maccio A.
Mantovani G, et al. Among authors: camboni p.
Int J Oncol. 2002 Feb;20(2):419-27.
Int J Oncol. 2002.
PMID: 11788911
Clinical Trial.
Item in Clipboard
Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
Mantovani G, Macciò A, Madeddu C, Mura L, Massa E, Gramignano G, Lusso MR, Murgia V, Camboni P, Ferreli L.
Mantovani G, et al. Among authors: camboni p.
J Environ Pathol Toxicol Oncol. 2003;22(1):17-28. doi: 10.1615/jenvpathtoxoncol.v22.i1.20.
J Environ Pathol Toxicol Oncol. 2003.
PMID: 12678402
Item in Clipboard
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.
Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Madeddu C, Mura L, Mudu MC, Proto E, Tore G, Mura M, Macciò A, Ferreli A, Amichetti M.
Mantovani G, et al. Among authors: camboni p.
Oncol Rep. 2003 May-Jun;10(3):759-66.
Oncol Rep. 2003.
PMID: 12684655
Clinical Trial.
Item in Clipboard
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
Mantovani G, Macciò A, Madeddu C, Mura L, Massa E, Gramignano G, Lusso MR, Murgia V, Camboni P, Ferreli L.
Mantovani G, et al. Among authors: camboni p.
J Cell Mol Med. 2002 Oct-Dec;6(4):570-82. doi: 10.1111/j.1582-4934.2002.tb00455.x.
J Cell Mol Med. 2002.
PMID: 12611641
Free PMC article.
Clinical Trial.
Item in Clipboard
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status.
Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, Mulas C, Mudu MC, Murgia V, Camboni P, Massa E, Ferreli L, Contu P, Rinaldi A, Sanjust E, Atzei D, Elsener B.
Mantovani G, et al. Among authors: camboni p.
Int J Cancer. 2002 Mar 1;98(1):84-91. doi: 10.1002/ijc.10143.
Int J Cancer. 2002.
PMID: 11857390
Item in Clipboard
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression.
Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, Murgia V, Camboni P, Ferreli L, Mocci M, Massa E.
Mantovani G, et al. Among authors: camboni p.
Free Radic Res. 2003 Feb;37(2):213-23. doi: 10.1080/10715760303849.
Free Radic Res. 2003.
PMID: 12653210
Item in Clipboard
Cite
Cite